Northern New England Clinical and Translational Research Network
新英格兰北部临床和转化研究网络
基本信息
- 批准号:10841975
- 负责人:
- 金额:$ 275.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-03 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAgingAmericanAreaAtherosclerosisAwardBiometryCOVID-19COVID-19 pandemicCardiovascular DiseasesCenters of Research ExcellenceChronicClinical DataClinical InvestigatorClinical ResearchClinical TrialsCollaborationsCommunicationCommunitiesCommunity HealthCommunity OutreachCoupledCultural DiversityDataDevelopmentDiabetes MellitusDiseaseEducationEnvironmentEpidemiologyEvaluationExtramural ActivitiesFacultyFoundationsFundingFunding MechanismsGoalsGoverning BoardGrantHealthHealthcareHuman Papilloma Virus VaccineHuman ResourcesImmigrantInfrastructureInstitutionLeadershipLearningLinkMaineMalignant NeoplasmsMentorsMentorshipModelingNative AmericansNew EnglandNew HampshireObesityOpiate AddictionOpioidPassamaquoddy Tribe of MainePatient CarePeer ReviewPenobscotPilot ProjectsPlayPopulationPopulations at RiskPost-Acute Sequelae of SARS-CoV-2 InfectionPredispositionPrimary CarePublic HealthPublicationsRegistriesResearchResearch DesignResearch InfrastructureResearch PersonnelResearch SupportReservationsResource SharingResourcesRoleRuralRural HealthRural PopulationServicesSiteSubstance Use DisorderSubstance abuse problemTechnologyToxic Environmental SubstancesTrainingTraining ProgramsTranslational ResearchTribesUnited States Health Resources and Services AdministrationUnited States National Institutes of HealthUniversitiesUrban PopulationVermontcareerclinical investigationcohortcommunity based researchcommunity engagementcommunity involvementcoronavirus diseaseequity, diversity, and inclusionflexibilityfood insecurityhealth communicationhealth differencehealth disparityhealth equityimprovedinnovationlearning progressionnovelnovel strategiespatient orientedpost-COVID-19practice-based research networkprimary care practiceprogramsruralitysuburban communitiestechnical reporttelehealthunderserved communityurban underservedvaccine hesitancy
项目摘要
The long-term goal of the Northern New England Clinical and Translational Research Network (NNE-CTR),
composed of MaineHealth, the University of Vermont, and the University of Southern Maine, is to sustain a
clinical and translational research infrastructure that supports improvements in community health for northern
New England inhabitants. Maine and Vermont have the oldest populations in the U.S. and that, coupled with
rurality, predisposes residents to a range of disorders ranging from cancer to substance use disorders, food
insecurity, obesity, diabetes and cardiovascular disease. In addition, northern New England has a growing
underserved immigrant population, as well as a Native American population. Our communities have been
challenged by the Covid-19 pandemic, and we are addressing these challenges by linking primary care
practice centers with academic centers and developing innovative approaches to community-based research.
During our first four years, the NNE-CTR has built a strong foundation for clinical research. We partnered with
the oldest regional practice-based research network (PBRN), the Dartmouth Co-Op, and actively supported
successful NIH program applications, including two COBREs, two NCI program grants, an infrastructure grant
for a new Center for Biomedical Shared Resources, and a HRSA grant to build on the opioid treatment model
pioneered in Vermont. The NNE-CTR PI is playing a leadership role in coordinating a national CTR network,
including the CTR National COVID Cohort Collaborative (N3C), a registry to share clinical data on Covid-19
nationally, and the NIH-sponsored RECOVER trial, which will define the long-term sequelae of Covid-19. In
this renewal, we plan to expand our collaborations both regionally and nationally, strengthen our PBRN, and
embrace cultural diversity. We will strengthen Core resources that include: the Biostatistics, Epidemiology and
Research Design Core, which will improve data capability and research navigation services; the Professional
Development Core, which will offer an array of new educational and mentorship opportunities; the Pilot
Projects Program, which will provide new and flexible funding mechanisms to offer more support for
community-based projects; the Translational Research and Technology Core, offering state-of-the-art
technologies and training for new investigators, and the Community Engagement and Outreach Core, which
will build stronger bridges to underserved communities. We propose three specific aims: 1-Expand
infrastructure and resources to address clinical and translational research needs in northern New England; 2-
Strengthen clinical and translational research that addresses health equity and disparities encountered by at-
risk populations, including expansion of clinical trial access, telehealth, and mentored training programs for
new investigators; and 3-Accelerate regional and national collaborative initiatives within the IDeA networks
and through NIH such as N3C and RECOVER. In sum, we will strengthen the NNE-CTR through continuous
learning and improvement supported by the principles of diversity, inclusion, and equity.
北方新英格兰临床和转化研究网络(NNE-CTR)的长期目标,
由缅因健康,佛蒙特大学和南缅因州大学组成,是为了维持一个
支持改善北方社区卫生的临床和转化研究基础设施
新英格兰居民。缅因州和佛蒙特州拥有美国最古老的人口,
农村,使居民容易患上一系列疾病,从癌症到物质使用障碍,食物,
不安全感、肥胖、糖尿病和心血管疾病。此外,北方新英格兰的人口增长
服务不足的移民人口,以及美洲土著人口。我们的社区已经
新冠肺炎疫情的挑战,我们正在通过将初级保健
实践中心与学术中心,并开发创新的方法,以社区为基础的研究。
在我们的头四年,NNE-CTR已经建立了临床研究的坚实基础。我们与
最古老的区域实践研究网络(PBRN),达特茅斯合作,并积极支持
成功的NIH计划申请,包括两个COBREs,两个NCI计划赠款,一个基础设施赠款
建立一个新的生物医学共享资源中心,并获得HRSA赠款,以建立阿片类药物治疗模式
在佛蒙特州开创。NNE-CTR PI在协调国家CTR网络方面发挥领导作用,
包括CTR国家COVID队列协作组织(N3 C),这是一个分享COVID-19临床数据的注册机构
以及NIH赞助的RECOVER试验,该试验将定义COVID-19的长期后遗症。在
这次更新,我们计划扩大我们在区域和国家两级的合作,加强我们的PBRN,
拥抱文化多样性。我们将加强核心资源,包括:生物统计学、流行病学和
研究设计核心,这将提高数据能力和研究导航服务;
发展核心,这将提供一系列新的教育和指导机会;试点
项目计划,该计划将提供新的和灵活的供资机制,以提供更多的支持,
社区项目;转化研究和技术核心,提供最先进的
新调查人员的技术和培训,以及社区参与和外展核心,
将为服务不足的社区搭建更牢固的桥梁。我们提出三个具体目标:1-扩大
满足北方新英格兰临床和转化研究需求的基础设施和资源; 2-
加强临床和转化研究,解决卫生公平和差距所遇到的at-
风险人群,包括扩大临床试验访问,远程医疗,和指导培训计划,
新的研究人员; 3-加快在IDEA网络内的区域和国家合作计划
如N3 C和RECOVER。总括而言,我们会继续透过以下措施,
学习和改进的多样性,包容性和公平的原则支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLIFFORD JAMES ROSEN其他文献
CLIFFORD JAMES ROSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLIFFORD JAMES ROSEN', 18)}}的其他基金
Northern New England Clinical and Translational Research Network
新英格兰北部临床和转化研究网络
- 批准号:
10681809 - 财政年份:2021
- 资助金额:
$ 275.26万 - 项目类别:
Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted Interventions
了解影响移民低收入和无家可归人群的 COVID-19 检测和疫苗接种的因素以及测试有针对性的干预措施
- 批准号:
10413438 - 财政年份:2021
- 资助金额:
$ 275.26万 - 项目类别:
Northern New England Clinical and Translational Research Network
新英格兰北部临床和转化研究网络
- 批准号:
10675577 - 财政年份:2017
- 资助金额:
$ 275.26万 - 项目类别:
Northern New England Clinical and Translational Research Network-Equipment
新英格兰北部临床和转化研究网络设备
- 批准号:
10797663 - 财政年份:2017
- 资助金额:
$ 275.26万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 275.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 275.26万 - 项目类别:
Standard Grant